Autoimmune retinopathy other diagnostic studies

Jump to navigation Jump to search

Autoimmune retinopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune retinopathy from other Diseases

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune retinopathy other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune retinopathy other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune retinopathy other diagnostic studies

CDC on Autoimmune retinopathy other diagnostic studies

Autoimmune retinopathy other diagnostic studies in the news

Blogs on Autoimmune retinopathy other diagnostic studies

Directions to Hospitals Treating Autoimmune retinopathy

Risk calculators and risk factors for Autoimmune retinopathy other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S

Overview

Other diagnostic studies that may play an important role in the diagnosis of autoimmune retinopathy include, fluorescein angiography (FA), optical coherence tomography (OCT), and fundus autofluorescence (FAF).

Fluorescein angiography shows leakage of retinal vasculature. Optical coherence tomography shows cystoid macular edema. On fundus autofluorescence, parafoveal hyperautofluorescent ring was seen, which showed a disruption of the inner-outer segment junction and thin outer nuclear and photoreceptor layers on spectral domain. Immunohistochemistry may also be used to localize the binding of anti-retinal antibodies to the cellular structures in the retinal tissue.  However, this is the least sensitive technique, and is unable to determine the type of autoimmune retinopathy. ELISA is more sensitive than immunohistochemistry, but it requires identification of the antigen of interest before testing.

Other Diagnostic Studies

Other ancillary tests may aid in the diagnosis of autoimmune retinopathy (AIR), which include, fluorescein angiography (FA), optical coherence tomography (OCT), and fundus autofluorescence (FAF).

Fluorescein angiography

On fluorescein angiography, leakage of retinal vasculature is seen.

Optical coherence tomography

On optical coherence tomography, cystoid macular edema is observed.

Fundus autofluorescence

On fundus autofluorescence, parafoveal hyperautofluorescent ring was seen, which showed a disruption of the inner-outer segment junction and thin outer nuclear and photoreceptor layers on spectral domain.

Immunohistochemistry

Immunohistochemistry may also be used to localize the binding of anti-retinal antibodies to the cellular structures in the retinal tissue.  However, this is the least sensitive technique, and is unable to determine the type of autoimmune retinopathy. [1]

ELISA

Unlike immunohistochemistry, ELISA is highly sensitive, but it requires identification of the antigen of interest before testing.

References

  1. Sen HN, Grange L, Akanda M, Fox A (2017). "Autoimmune Retinopathy: Current Concepts and Practices (An American Ophthalmological Society Thesis)". Trans Am Ophthalmol Soc. 115: T8. PMC 5844289. PMID 29576753.


Template:WH Template:WS